SCHEMBL2422607

SCHEMBL2422607

c1ccc(Nc2ccccc2-c2ncccn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
MAPT P10636 5/20 0.47
TDP1 Q9NUW8 5/20 0.47
KDM4E B2RXH2 3/20 0.47
GAA P10253 2/20 0.47
GLA P06280 2/20 0.47
RECQL P46063 1/20 0.47
ALDH1A1 P00352 6/20 0.45
LMNA P02545 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
HSD17B10 Q99714 3/20 0.42
ALOX15 P16050 2/20 0.42
TSHR P16473 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18966077 0.81 KMT2A (0.49) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL29850028 0.81 KMT2A (0.49) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL13363917 0.80 MAPT (0.61) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL29871430 0.78 MAPT (0.58) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL29257205 0.76 MAPT (0.56) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL28229136 0.76 TAS2R14 (0.38) MEN1KMT2AMAPTKDM4EGAA
SCHEMBL23978923 0.75 ADRA1D (0.45) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL9693871 0.75 ADRA1D (0.45) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL588648 0.74 FABP4 (0.55) MEN1KMT2AMAPTTDP1KDM4E
Benzene SCHEMBL28417037 0.74 FABP4 (0.55) MEN1KMT2AMAPTTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366699-B1 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2013-08-07 EP disclosed
US-8299055-B2 8-substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2012-10-30 US disclosed
EP-2366699-A1 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2011-09-21 EP disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof RELA, NFKBIA, NFKB2 MEN1 2532/4885KMT2A 637/4885MAPT 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.